Physician profile
Peter Koon
NPI 1780974642
$1,653.87
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $759 · 2021: $368 · 2023: $180 · 2024: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $397.54 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $241.20 | 2021 | |
| Exthera Medical Corporation | $180.09 | 2023 | |
| Inari Medical, INC. | $155.29 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pulmonx Corporation | $146.33 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Glaxosmithkline, LLC. | $126.55 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.41 | 2019 | |
| Insmed, INC. | $120.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $118.81 | 2019 | |
| Abiomed | $27.50 | 2024 | Impella |
| Erbe USA INC | $18.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Koon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.